Insulet
PODD
#1049
Rank
$21.43 B
Marketcap
$304.49
Share price
-3.62%
Change (1 day)
13.79%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Revenue for Insulet (PODD)

Revenue in 2025 (TTM): $2.52 Billion USD

According to Insulet's latest financial reports the company's current revenue (TTM ) is $2.52 Billion USD. In 2024 the company made a revenue of $2.07 Billion USD an increase over the revenue in the year 2023 that were of $1.69 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Insulet from 2006 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $2.52 B21.74%
2024 $2.07 B22.07%
2023 $1.69 B30.02%
2022 $1.30 B18.79%
2021 $1.09 B21.49%
2020 $0.90 B22.52%
2019 $0.73 B30.93%
2018 $0.56 B21.57%
2017 $0.46 B26.37%
2016 $0.36 B30.97%
2015 $0.28 B-2.95%
2014 $0.28 B16.85%
2013 $0.24 B16.9%
2012 $0.21 B38.83%
2011 $0.15 B57.02%
2010 $96.96 M46.85%
2009 $66.03 M83.12%
2008 $36.05 M169.66%
2007 $13.37 M242.08%
2006 $3.9 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ICU Medical
ICUI
$2.32 B-7.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
$1.00 B-60.07%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
$4.51 B 79.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$92.14 B 3,553.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$43.84 B 1,638.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
$34.20 B 1,256.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
$59.41 B 2,256.15%๐Ÿ‡บ๐Ÿ‡ธ USA